SIRT1 interacts with and protects glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from nuclear translocation: Implications for cell survival after irradiation

Biochemical and Biophysical Research Communications

Volumn 424, Issue 4, 2012, Pages 681-686

  Joo, Hyun Yoo ^a,c   Woo, Seon Rang ^a   Shen, Yan Nan ^a   Yun, Mi Yong ^a   Shin, Hyun Jin ^a   Park, Eun Ran ^a   Kim, Su Hyeon ^a   Park, Jeong Eun ^a   Ju, Yeun Jin ^a   Hong, Sung Hee ^a   Hwang, Sang Gu ^a   Cho, Myung Haing ^b   Kim, Joon ^c   Lee, Kee Ho ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Seoul National University   (South Korea)

^c Korea University   (South Korea)

Author keywords

GAPDH; Interaction; Irradiation; Nuclear translocation; SIRT1; Survival

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; SIRTUIN 1;

APOPTOSIS; ARTICLE; CELL STRESS; CELL SURVIVAL; CYTOSOL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IRRADIATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; CELL NUCLEUS; CELL SURVIVAL; CYTOSOL; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); HELA CELLS; HUMANS; RADIATION TOLERANCE; RNA, SMALL INTERFERING; SIRTUIN 3;

EID: 84864824982     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.006     Document Type: Article

References (29)

1. Sirover M.A. New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. J. Cell. Biochem. 2005, 95:45-52.
2. Sen N., Hara M.R., Kornberg M.D., Cascio M.B., Bae B.I., Shahani N., Thomas B., Dawson T.M., Dawson V.L., Snyder S.H., Sawa A. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat. Cell Biol. 2008, 10:866-873.
3. Robbins A.R., Ward R.D., Oliver C. A mutation in glyceraldehyde-3-phosphate dehydrogenase alters endocytosis in CHO cells. J. Cell Biol. 1995, 130:1093-1104.
4. Zheng L., Roeder R.G., Luo Y. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell 2003, 114:255-266.
5. Azam S., Jouvet N., Jilani A., Vongsamphanhn R., Tang X., Yang S., Ramotar D. Human glyceraldehyde-3-phosphate dehydrogenase plays a direct role in reactivating oxidized forms of the DNA repair enzyme APE1. J. Biol. Chem. 2008, 283:30632-30641.
6. Mohr S., Stamler J.S., Brune B. Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment. J. Biol. Chem. 1996, 271:4209-4214.
7. Hara M.R., Agrawal N., Kim S.F., Cascio M.B., Fujimuro M., Ozeki Y., Takahashi M., Cheah J.H., Tankou S.K., Hester L.D., Ferris C.D., Hayward S.D., Snyder S.H., Sawa A. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat. Cell Biol. 2005, 7:665-674.
8. Hara M.R., Snyder S.H. Nitric oxide-GAPDH-Siah : a novel cell death cascade. Cell. Mol. Neurobiol. 2006, 26:527-539.
9. Lill N.L., Grossman S.R., Ginsberg D., DeCaprio J., Livingston D.M. Binding and modulation of p53 by p300/CBP coactivators. Nature 1997, 387:823-827.
10. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
11. Bouras T., Fu M., Sauve A.A., Wang F., Quong A.A., Perkins N.D., Hay R.T., Gu W., Pestell R.G. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J. Biol. Chem. 2005, 280:10264-10276.
12. Finkel T., Deng C.X., Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460:587-591.
13. Guarente L. Sirtuins as potential targets for metabolic syndrome. Nature 2006, 444:868-874.
14. Chaudhary N., Pfluger P.T. Metabolic benefits from Sirt1 and Sirt1 activators. Curr. Opin. Clin. Nutr. Metab. Care. 2009, 12:431-437.
15. Schlicker C., Gertz M., Papatheodorou P., Kachholz B., Becker C.F., Steegborn C. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J. Mol. Biol. 2008, 382:790-801.
16. Someya S., Yu W., Hallows W.C., Xu J., Vann J.M., Leeuwenburgh C., Tanokura M., Denu J.M., Prolla T.A. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010, 143:802-812.
17. 2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. J. Cell Mol. Med. 2009, 13:3632-3643.
18. Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001, 107:137-148.
19. Vaziri H., Dessain S.K., Ng Eaton E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., Weinberg R.A. HSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001, 107:149-159.
20. Wang C., Chen L., Hou X., Li Z., Kabra N., Ma Y., Nemoto S., Finkel T., Gu W., Cress W.D., Chen J. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat. Cell Biol. 2006, 8:1025-1031.
21. Lee H.C., An S., Lee H., Woo S.H., Jin H.O., Seo S.K., Choe T.B., Yoo D.H., Lee S.J., Hong Y.J., Park M.J., Rhee C.H., Park I.C., Hong S.I. Activation of epidermal growth factor receptor and its downstream signaling pathway by nitric oxide in response to ionizing radiation. Mol. Cancer Res. 2008, 6:996-1002.
22. Saunders L.R., Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 2007, 26:5489-5504.
23. Brooks C.L., Gu W. How does SIRT1 affect metabolism, senescence and cancer?. Nat. Rev. Cancer 2009, 9:123-128.
24. Du Z.X., Wang H.Q., Zhang H.Y., Gao D.X. Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells. Endocrinology 2007, 148:52-61.
25. Lee S.Y., Kim J.H., Jung H., Chi S.W., Chung S.J., Lee C.K., Park B.C., Bae K.H., Park S.G. Glyceraldehyde-3-phosphate, a glycolytic intermediate, prevents cells from apoptosis by lowering S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase. J. Microbiol. Biotechnol. 2012, 22:571-573.
26. Lee K.H., Rudolph K.L., Ju Y.J., Greenberg R.A., Cannizzaro L., Chin L., Weiler S.R., DePinho R.A. Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Proc. Nat. Acad. Sci. U.S.A. 2001, 98:3381-3386.
27. Park J.E., Woo S.R., Kang C.M., Juhn K.M., Ju Y.J., Shin H.J., Joo H.Y., Park E.R., Park I.C., Hong S.H., Hwang S.G., Lee J.K., Kim H.K., Cho M.H., Park G.H., Lee K.H. Paclitaxel stimulates chromosomal fusion and instability in cells with dysfunctional telomeres: implication in multinucleation and chemosensitization. Biochem. Biophys. Res. Commun. 2011, 404:615-621.
28. Woo S.R., Park J.E., Juhn K.M., Ju Y.J., Jeong J., Kang C.M., Yun H.J., Yun M.Y., Shin H.J., Joo H.T., Park E.R., Park I.C., Hong S.H., Hwang S.G., Kim H., Cho M.H., Kim S.H., Park G.H., Lee K.H. Cells with dysfunctional telomeres are susceptible to reactive oxygen species hydrogen peroxide via generation of multichromosomal fusions and chromosomal fragments bearing telomeres. Biochem. Biophys. Res. Commun. 2012, 417:204-210.
29. Dastoor Z., Dreyer J.L. Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. J. Cell Sci. 2001, 114:1643-1653.